Hans Vos

1.2k total citations
17 papers, 971 citations indexed

About

Hans Vos is a scholar working on Pathology and Forensic Medicine, Genetics and Hematology. According to data from OpenAlex, Hans Vos has authored 17 papers receiving a total of 971 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pathology and Forensic Medicine, 6 papers in Genetics and 5 papers in Hematology. Recurrent topics in Hans Vos's work include Lymphoma Diagnosis and Treatment (8 papers), Chronic Lymphocytic Leukemia Research (4 papers) and Blood Coagulation and Thrombosis Mechanisms (4 papers). Hans Vos is often cited by papers focused on Lymphoma Diagnosis and Treatment (8 papers), Chronic Lymphocytic Leukemia Research (4 papers) and Blood Coagulation and Thrombosis Mechanisms (4 papers). Hans Vos collaborates with scholars based in Netherlands, China and Germany. Hans Vos's co-authors include Sibrand Poppema, Lydia Visser, Harry Hollema, Frits R. Rosendaal, Rogier M. Bertina, Pieter W. Kamphuisen, Jeroen Eikenboom, Auguste Sturk, Anke van den Berg and Arjan Diepstra and has published in prestigious journals such as Blood, PLoS ONE and European Journal of Immunology.

In The Last Decade

Hans Vos

17 papers receiving 941 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Hans Vos Netherlands	12	371	334	228	217	157	17	971
Luca Laurenti Italy	14	351 0.9×	239 0.7×	277 1.2×	274 1.3×	389 2.5×	41	1.1k
Giuseppe Gritti Italy	17	392 1.1×	628 1.9×	651 2.9×	138 0.6×	298 1.9×	59	1.2k
Takafumi Matsushima Japan	17	209 0.6×	266 0.8×	200 0.9×	417 1.9×	263 1.7×	57	933
D Guyotat France	16	91 0.2×	142 0.4×	121 0.5×	274 1.3×	153 1.0×	52	659
Inmaculada Heras Spain	17	163 0.4×	201 0.6×	281 1.2×	494 2.3×	112 0.7×	44	962
Vera Malkovska United States	13	279 0.8×	84 0.3×	155 0.7×	211 1.0×	72 0.5×	43	623
Ingrid Simonitsch Austria	22	361 1.0×	498 1.5×	357 1.6×	365 1.7×	244 1.6×	54	1.4k
Edward H. Lipford United States	15	429 1.2×	460 1.4×	451 2.0×	68 0.3×	214 1.4×	32	1.1k
Hellmut Ottinger Germany	21	834 2.2×	70 0.2×	330 1.4×	987 4.5×	153 1.0×	49	1.6k
Hilde De Winter United States	11	810 2.2×	75 0.2×	117 0.5×	339 1.6×	189 1.2×	32	1.2k

Countries citing papers authored by Hans Vos

Since Specialization

Citations

This map shows the geographic impact of Hans Vos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hans Vos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hans Vos more than expected).

Fields of papers citing papers by Hans Vos

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hans Vos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hans Vos. The network helps show where Hans Vos may publish in the future.

Co-authorship network of co-authors of Hans Vos

This figure shows the co-authorship network connecting the top 25 collaborators of Hans Vos. A scholar is included among the top collaborators of Hans Vos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hans Vos. Hans Vos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Plattel, Wouter J., Anke van den Berg, Leo H. Visser, et al.. (2011). Plasma thymus and activation-regulated chemokine as an early response marker in classical Hodgkin's lymphoma. Haematologica. 97(3). 410–415. 47 indexed citations

Nolte, Ilja M., Zifen Gao, Hans Vos, et al.. (2011). Epidemiology of Classical Hodgkin Lymphoma and Its Association with Epstein Barr Virus in Northern China. PLoS ONE. 6(6). e21152–e21152. 32 indexed citations

Xu, Chuanhui, Wouter J. Plattel, Anke van den Berg, et al.. (2011). Expression of the c-Met oncogene by tumor cells predicts a favorable outcome in classical Hodgkin's lymphoma. Haematologica. 97(4). 572–578. 22 indexed citations

Berg, Anke van den, Zifen Gao, Lydia Visser, et al.. (2010). Expression of HLA Class I and HLA Class II by Tumor Cells in Chinese Classical Hodgkin Lymphoma Patients. PLoS ONE. 5(5). e10865–e10865. 15 indexed citations

Plattel, Wouter J., Anke van den Berg, Hans Vos, et al.. (2010). Mid-Treatment Plasma Levels of Thymus Activated and Regulated Chemokine (TARC) Predict Treatment Outcome In Classical Hodgkin Lymphoma Patients. Blood. 116(21). 748–748. 4 indexed citations

Xu, Chuanhui, Anke van den Berg, Arjan Diepstra, et al.. (2009). The HGF/c-Met Signaling Pathway in Hodgkin Lymphoma.. Blood. 114(22). 1551–1551. 1 indexed citations

Doggen, Carine J.M., Hans Vos, P.H. Reitsma, Frits R. Rosendaal, & Elisabeth R. Pomp. (2008). Polymorphisms in the protein C gene as risk factor for venous thrombosis. Thrombosis and Haemostasis. 101(1). 62–67. 30 indexed citations

Ma, Yue, Lydia Visser, Han Roelofsen, et al.. (2007). Proteomics analysis of Hodgkin lymphoma: identification of new players involved in the cross-talk between HRS cells and infiltrating lymphocytes. Blood. 111(4). 2339–2346. 96 indexed citations

Berg, Anke van den, Geert Harms, Hans Vos, et al.. (2006). Strongly enhanced IL-10 production using stable galectin-1 homodimers. Molecular Immunology. 44(4). 506–513. 85 indexed citations

10.

Doggen, Carine J.M., et al.. (2000). The HR2 Haplotype of Factor V Is not Associated with the Risk of Myocardial Infarction. Thrombosis and Haemostasis. 84(11). 815–818. 11 indexed citations

11.

Kamphuisen, Pieter W., Jeroen Eikenboom, Hans Vos, et al.. (1999). Increased Levels of Factor VIII and Fibrinogen in Patients with Venous Thrombosis Are not Caused by Acute Phase Reactions. Thrombosis and Haemostasis. 81(5). 680–683. 212 indexed citations

12.

Vos, Hans, et al.. (1999). No Indication for APTT Screening in Patients on Oral Anticoagulant Therapy. Thrombosis and Haemostasis. 81(3). 364–366. 11 indexed citations

13.

Timens, Wim, Adriana Boes, Hans Vos, & S. Poppema. (1991). Tissue distribution of the C3d/EBV-receptor: CD21 monoclonal antibodies reactive with a variety of epithelial cells, medullary thymocytes, and peripheral T-cells. Histochemistry and Cell Biology. 95(6). 605–611. 40 indexed citations

14.

Shaw, Andrew, et al.. (1989). Monoclonal antibodies reactive with hairy cell leukemia [see comments]. Blood. 74(1). 320–325. 72 indexed citations

15.

Shaw, Alan, et al.. (1989). Monoclonal antibodies reactive with hairy cell leukemia [see comments]. Blood. 74(1). 320–325. 4 indexed citations

16.

Poppema, Sibrand, Harry Hollema, Lydia Visser, & Hans Vos. (1987). Monoclonal antibodies (MT1, MT2, MB1, MB2, MB3) reactive with leukocyte subsets in paraffin-embedded tissue sections.. PubMed. 127(3). 418–29. 210 indexed citations

17.

Kroese, Frans G. M., et al.. (1987). B lymphocyte differentiation in the rat: production and characterization of monoclonal antibodies to B lineage‐associated antigens. European Journal of Immunology. 17(7). 921–928. 79 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact